Search

Your search keyword '"Mercimek-Andrews, Saadet"' showing total 287 results

Search Constraints

Start Over You searched for: Author "Mercimek-Andrews, Saadet" Remove constraint Author: "Mercimek-Andrews, Saadet"
287 results on '"Mercimek-Andrews, Saadet"'

Search Results

2. Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurement

5. Assessing the quality and value of metabolic chart data for capturing core outcomes for pediatric medium-chain acyl-CoA dehydrogenase (MCAD) deficiency

7. Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort

8. Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

12. Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study

13. Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders.

14. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling.

17. Disruptive mutations in TANC2 define a neurodevelopmental syndrome associated with psychiatric disorders.

19. Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L GATM variant and study of organoids towards treatment.

20. De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder

21. Clinical Characteristics of Creatine Transporter Deficiency (CTD): Final Results of the Vigilan Observational Study (P8-8.002)

23. The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency

26. PIGG variant pathogenicity assessment reveals characteristic features within 19 families

27. Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons

28. Functional divergence of the two Elongator subcomplexes during neurodevelopment

29. Dissecting CASK: Novel splice site variant associated with male MICPCH phenotype.

30. Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

32. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

33. Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study

34. Next generation of free? Points to consider when navigating sponsored genetic testing.

37. Correction: Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons

39. Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy

41. Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing

44. O04: Developing a framework for sequence variant interpretation for multiple X-linked inborn errors of metabolism: The ClinGen IEM Working Group Experience

46. sj-docx-1-trd-10.1177_26330040221150269 – Supplemental material for Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series

48. Diagnostic yield of clinical exome sequencing in adulthood in medical genetics clinics

Catalog

Books, media, physical & digital resources